Cargando…
T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
The competent immune system controls disease effectively due to induction, function, and regulation of effector lymphocytes. Immunosurveillance is exerted mostly by cytotoxic T-lymphocytes (CTLs) while specific immune suppression is associated with tumor malignancy and progression. In squamous cell...
Autores principales: | Albers, A. E., Strauss, L., Liao, T., Hoffmann, T. K., Kaufmann, A. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017942/ https://www.ncbi.nlm.nih.gov/pubmed/21234340 http://dx.doi.org/10.1155/2010/236378 |
Ejemplares similares
-
A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
por: Chen, Chao, et al.
Publicado: (2010) -
Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
por: Chen, Chao, et al.
Publicado: (2011) -
Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020) -
Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety
por: Qian, Xu, et al.
Publicado: (2015) -
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer
por: Klinghammer, Konrad, et al.
Publicado: (2020)